Email Us
Hot Products from CapitalBio Technology
Fully Integrated Platform for COVID-19
Working with microfluidic chips, it adopts multiple advanced technologies, and integrates nucleic acid extraction, nested isothermal amplification, and real-time fluorescence detection within one.
Instruments
Fully Integrated Platform for COVID-19
Microfluidic Platform
The perfect combination of microfluidic technology and isothermal amplification technology meets the current needs of high-throughput, economical, and efficient rapid testing in food safety, clinical diagnosis, and other fields.
Instruments
Microfluidic Platform
Microarray Platform
An ideal micro-environment for hydrodynamic and molecular thermodynamic hybridization reactions, and enhance reaction signals and improve consistency of results.
Instruments
Microarray Platform
Next Generation Sequencing Platform
CapitalBio®BioelectronSeq 4000 Sequencer: The system adopts semiconductor sequencing technology. Working with clinical testing kits, automated data analysis and management software, it is ideal for clinical laboratories.
Instruments
Next Generation Sequencing Platform
IMAP Platform
The platform integrates a series of operations such as biological sample loading, PCR reaction, fluorescence in situ detection, etc., to achieve high-throughput, flexible and accurate SNP/InDel detection.
Instruments
IMAP Platform
Forensic Platform
A forensic DNA test using microfluidic technology can be conducted in two hours or less.
Instruments
Forensic Platform
CapitalBio® CalSlide-III Calibration Slide
It can be used to calibrate and maintain microarray fluorescence scanners and compare signal intensities. It's needed for microarray analysis and detection.
Consumbles
CapitalBio® CalSlide-III Calibration Slide
Hybridization Box
It is intended to hold a 25mm 75mm microarray slide in an isolated environment to prevent the hybridization solution from evaporating.
Consumbles
Hybridization Box
Solutions for Infectious Disease Control
CapitalBio provides comprehensive control solutions for infectious diseases, such as Respiratory Pathogens related diseases and Tuberculosis Bacteria related diseases, in order to assist clinicians in formulating precise diagnoses and treatment plans.
Health Solutions
Solutions for Infectious Disease Control
Solutions for Maternal and Child Healthcare
Based on the powerful testing platform and independent research and development capabilities, CapitalBio formed a congenital disability prevention and control program including NIPT, NIPT-PLUS, CNV-seq, and Deafness-related Gene Mutation detection, escort for the health of women and children.
Health Solutions
Solutions for Maternal and Child Healthcare
Solutions for Anti-cancer Therapy
The new model of cancer diagnosis and treatment is genetic testing combined with targeted therapy, which will enhance both the effective rate and overall survival of cancer patients. CapitalBio anti-cancer solutions cover all stages of cancer development, from diagnosis to treatment to prognosis.
Health Solutions
Solutions for Anti-cancer Therapy
Solutions for Pharmacogenomics
Based on pharmacogenomics, Pharmacogenomics Testing makes prescription safer and more effective by detecting genes associated with drug metabolism, efficacy, and side effects. Given the stability of genes and the irreversibility of the impact of many ADRs, the test would benefit the entire life.
Health Solutions
Solutions for Pharmacogenomics
Other Health Solutions
Provide personalized solutions based on the needs of the customer.
Health Solutions
Other Health Solutions
Sequencing Service
Sequencing Service
With 20+ years’ experience, national scientific research platforms and bioinformatics expertise, Capitalbio Technology always dedicated to assisting researchers advance the life sciences. We have professional scientists to provide services for the whole process, from free consulting and experiment design to data interpretation.
View More
CapitalBio
About CapitalBio

CapitalBio Technology Co, Ltd. is the industrialized platform of CapitalBio Corporation and Biochip Beijing National Engineering Research Center and one of the core enterprises of Tsinghua University in the field of life and health. CapitalBio Technology was registered and established in August 2012 and had production, R&D bases and marketing operation centers for biochips, instrument and equipment in Beijing, Shanghai, Chongqing, Chengdu, Dongguan, Hong Kong (China) and San Diego and other places, with a total office area of over 150,000 ㎡ and employees of over 2,000 persons.

View More
about capitalbio
biochip company
biotech companies genetic sequencing
biotech genetic sequencing companies
biotech sequencing companies
Please Contact CapitalBio for More Information on Health Solutions
And Sequencing Services!
86-10-69002900
Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing